Infectious disease
Alpha Variant B.1.1.7 SCoV2 (Spike Glycoprotein) Peptide Pool
€316.90*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Caution:
For research use only. Not for use in humans.
1
Product number: LB01944
Description
This peptide pool with 31 peptides covers all mutations in the Spike Glycoprotein derived from the alpha variant B.1.1.7 of SARS-CoV-2 which emerged in Britain in December 2020 and is thought to be roughly 50 percent more infectious and now dominant in the U.S.
One unit allows the stimulation of 2,5 x 108 cells.
TechData
| Gene: | S |
| Delivery: | 1-3 days |
| Counterion: | TFA |
| No. Peptides: | 31 peptides |
| Amount/Aliquote: | 15 nmol (approx. 25µg)/peptide for stimulation of 2,5 x 108 cells |
| Solubility: | Dissolve in a minimum amount of pure DMSO (40µl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological system. |
| Protein: | Spike glycoprotein |
| UniProt Id: | P0DTC2 |
| Species: | SARS-CoV-2 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease |